Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07561255
Recruiting
Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia.
Not applicable · Germany · 7 sites
Registry update: 1 May 2026
2025-523996-45-00
Recruiting
The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes
Phase 4 · Denmark · 1 site
Registry update: 16 Mar 2026
NCT07555470
Recruiting
Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma
Phase 2 · China · 1 site
Registry update: 9 Jun 2026
NCT07020065
Recruiting
Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
Phase 2 · Switzerland · 18 sites
Registry update: 28 Oct 2026
NCT07724847
Recruiting
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Not applicable · China · 1 site
Registry update: 24 Jul 2026
NCT07508215
Recruiting
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
Not applicable · China · 2 sites
Registry update: 6 Jul 2026
NCT07752446
Recruiting
Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission
Not applicable · Chile · 1 site
Registry update: 7 Aug 2026
NCT07717333
Recruiting
Sarcopenia Indicators After Bariatric Surgery
Not applicable · 1 site
Registry update: 21 Jul 2026
NCT07457151
Recruiting
Danicopan PMS in Korea
Not applicable · South Korea · 3 sites
Registry update: 13 Oct 2026
NCT07725250
Recruiting
Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
Not applicable · United States · 1 site
Registry update: 24 Jul 2026
NCT07175441
Recruiting
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Phase 2 · United States · 4 sites
Registry update: 24 Apr 2026
NCT07318948
Recruiting
BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Not applicable · China · 2 sites
Registry update: 1 Sept 2026
NCT07603960
Recruiting
Whole-Body Cryotherapy as a Non-Pharmacological Treatment to Reduce Chronic Pelvic Pain and Improve Quality of Life in People With Endometriosis
Not applicable · United Kingdom · 1 site
Registry update: 22 May 2026
NCT07627542
Recruiting
An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis
Not applicable · 1 site
Registry update: 9 Jun 2026
NCT07191418
Recruiting
Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors
Not applicable · Sweden · 1 site
Registry update: 24 Aug 2026
NCT07563322
Recruiting
Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
Not applicable · United States · 1 site
Registry update: 4 May 2026
NCT07349030
Recruiting
Fall Risk Intervention for Stroke
Not applicable · United States · 1 site
Registry update: 3 Jun 2026
NCT07398157
Recruiting
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT07522073
Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3 · Austria, Australia, Belgium, Canada, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Georgia, Italy, Japan, South Korea, Netherlands, Norway, New Zealand, Poland, Puerto Rico, Sweden, United States · 230 sites
Registry update: 30 Oct 2026
NCT07060001
Recruiting
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
Phase 2 · United States · 1 site
Registry update: 8 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.